OR WAIT null SECS
March 13, 2024
The company is investing more than $2 million in its analytical testing services and adding suppository manufacturing capabilities.
February 15, 2024
The company’s Itasca, Ill., facility will offer chemistry, manufacturing, and controls analytical testing support.
February 02, 2024
Under a new collaboration, Lonza and Oxford Nanopore aim to commercialize a CGMP-validated test for advanced analysis of mRNA products.
February 01, 2024
Strategizing a PK/PD study approach in early phase development facilitates a successful clinical progression.
December 01, 2023
Sufficient stability studies show a drug product meets regulatory requirements, therefore ensuring the drug reaches the patients who rely on it.
November 27, 2023
MilliporeSigma has expanded its biosafety testing laboratories in Shanghai, China, with the completion of new lab space at its new €29 million (US$43 million) Biologics Testing Center.
November 02, 2023
The new centralized hub will provide advanced testing of nucleic acids, which is expected to simplify mRNA substance testing.
September 20, 2023
CN Bio and LifeNet Health LifeSciences have teamed up to provide direct access to a portfolio of highly characterized hepatic cells for the creation of advanced liver-on-a-chip assays.
September 07, 2023
Illumina’s new solutions center in Bengaluru, India, will expand access to genomics in the country.
May 01, 2023
Preclinical studies specifically benefit from the “smart” drug development trend through deeper data access and analysis.